1. Home
  2. ESCA vs AKBA Comparison

ESCA vs AKBA Comparison

Compare ESCA & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

N/A

Current Price

$19.51

Market Cap

257.2M

ML Signal

N/A

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.88

Market Cap

248.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESCA
AKBA
Founded
1922
2007
Country
United States
United States
Employees
N/A
194
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.2M
248.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ESCA
AKBA
Price
$19.51
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $4.67
AVG Volume (30 Days)
21.0K
★ 7.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
★ 3.50%
N/A
EPS Growth
6.45
★ 93.94
EPS
★ 1.00
N/A
Revenue
★ $180,541,000.00
N/A
Revenue This Year
$4.15
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.52
★ N/A
Revenue Growth
★ 2.71
N/A
52 Week Low
$11.41
$0.81
52 Week High
$23.07
$3.19

Technical Indicators

Market Signals
Indicator
ESCA
AKBA
Relative Strength Index (RSI) 44.64 40.80
Support Level $19.35 $0.85
Resistance Level $21.23 $0.96
Average True Range (ATR) 0.48 0.05
MACD -0.03 0.00
Stochastic Oscillator 36.81 4.08

Price Performance

Historical Comparison
ESCA
AKBA

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: